Skip to search boxSkip to navigationSkip to main content

Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population-based studies

  • R. M. Carrillo-Larco
    ,
  • D. J. Aparcana-Granda
    ,
  • J. R. Mejia
    ,
  • N. C. Barengo
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • Universidad Católica los Ángeles de Chimbote
    ,
  • Imperial College London
    ,
  • Universidad Nacional del Centro del Perú
    ,
  • Herbert Wertheim College of Medicine
    ,
  • R¯ıga Stradinš ¸ University (RSU)
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1573-1584 (12 pages)

Journal (Volume, Issue Number)

Diabetic Medicine (Volume 36, Issue 12)

Publication milestones

  • Published - 01/12/2019

Publication status

Published - 01/12/2019

ISSN

0742-3071

Publication IDs

  • Scopus: 85071891275
  • PubMed: 31441090

Abstract

Aim: To summarize the evidence on diabetes risk scores for Latin American populations. Methods: A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines. Results: Of the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66–72%) as per the area under the receiving-operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity. Conclusion: There is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention.

Funding Details

Strategic Award, Wellcome Trust-Imperial College Centre for Global Health Research (100693/Z/12/Z). Imperial College London Wellcome Trust Institutional Strategic Support Fund [Global Health Clinical Research Training Fellowship] (294834/Z/16/Z ISSF ICL). Rodrigo M Carrillo-Larco is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z). The funder had no role in the conception of this work, neither in the preparation or presentation of results. The authors are responsible for the results and opinions in this work.
FundersFunding numbers
Wellcome Trust‐Imperial College Centre for Global Health Research
100693/Z/12/Z
CGH
294834/Z/16/Z ISSF ICL
WT
214185/Z/18/Z
Imperial College London
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
17
Usage
104
Social media
43
Captures
126

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well